More options enter the vaccine game, but new variants loom large
POLITICO Get the Prescription Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by CVS Health On Tap — European leaders balk as AstraZeneca lags while Sanofi chips in for others. — HHS confident in syringe supply as providers scramble for needed vaccine tools. It’s Friday, welcome back to Prescription ...